📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Santarus

1.1 - Company Overview

Santarus Logo

Santarus

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty biopharmaceutical products focused on acquiring, developing and commercializing proprietary therapies that address the needs of patients treated by physician specialists; current commercial efforts encompass five products, including UCERIS (budesonide) extended release tablets.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Santarus

Medarex Logo

Medarex

HQ: United States Website
  • Description: Provider of fully human antibody-based therapeutics, focused on discovering, developing and commercializing treatments for life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases, leveraging its UltiMAb technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medarex company profile →
Labopharm Logo

Labopharm

HQ: Canada Website
  • Description: Provider of specialty pharmaceutical solutions that optimize the performance of existing drugs using advanced controlled-release technologies; operates internationally.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Labopharm company profile →
NPS Pharmaceuticals Logo

NPS Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapies for rare diseases, dedicated to making a difference in the lives of patients who often have few, if any, treatment options.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NPS Pharmaceuticals company profile →
Allegro Ophthalmics Logo

Allegro Ophthalmics

HQ: United States Website
  • Description: Provider of integrin inhibition therapy focused on retinal diseases, including Risuteganib (Luminate), an investigational compound targeting mitochondrial dysfunction and oxidative stress to restore retinal homeostasis for intermediate dry age-related macular degeneration, and ALG-1007, a topical mitochondrial stabilizer in development for dry eye disease with promising clinical trial results.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allegro Ophthalmics company profile →
Sophos Biotech Logo

Sophos Biotech

HQ: Italy Website
  • Description: Provider of pharmaceutical medicines and drugs for the treatment of mucositis and prostate and breast oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sophos Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Santarus

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Santarus

2.2 - Growth funds investing in similar companies to Santarus

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Santarus

4.2 - Public trading comparable groups for Santarus

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Santarus

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Santarus

What does Santarus do?

Santarus is a provider of specialty biopharmaceutical products focused on acquiring, developing and commercializing proprietary therapies that address the needs of patients treated by physician specialists; current commercial efforts encompass five products, including UCERIS (budesonide) extended release tablets.

Who are Santarus's competitors?

Santarus's competitors and similar companies include Medarex, Labopharm, NPS Pharmaceuticals, Allegro Ophthalmics, and Sophos Biotech.

Where is Santarus headquartered?

Santarus is headquartered in United States.

How many employees does Santarus have?

Santarus has 1,000 employees 🔒.

When was Santarus founded?

Santarus was founded in 2010 🔒.

What sector and industry vertical is Santarus in?

Santarus is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Santarus

Who are the top strategic acquirers in Santarus's sector and industry

Top strategic M&A buyers and acquirers in Santarus's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Santarus?

Top strategic M&A buyers groups and sectors for Santarus include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Santarus's sector and industry vertical

Which are the top PE firms investing in Santarus's sector and industry vertical?

Top PE firms investing in Santarus's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Santarus's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Santarus's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Santarus's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Santarus include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Santarus's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Santarus?

The key public trading comparables and valuation benchmarks for Santarus include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Santarus for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Santarus with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Santarus's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Santarus with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Santarus's' sector and industry vertical?

Access recent funding rounds and capital raises in Santarus's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Santarus